SEC Form 4 · accession 0001673528-26-000017
First Tracks Biotherapeutics, Inc. · TRAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Faga
Officer — President, CEO · Director
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002091349
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Stock UnitsF1,F2,F3 | — | Aug 15, 2026 | A | 193,575 | A | — | — | Common Stock | 193,575 | 440,485 | D |
Explanation of responses
- F1Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on August 15, 2026.
- F2Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
- F3The PSUs vest and settle over two years; 50% vests on August 15, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.